Learn more →
Back to Expert Scholars
cancer-immunology / cancer-immunologyT Cell Biology

Dan Littman

丹·利特曼

MD, PhD

🏢NYU Langone Health(纽约大学朗格尼健康)🌐USA

Kimberley and Eric J. Waldman Professor of Molecular Immunology分子免疫学金伯利与埃里克·沃尔德曼讲席教授

120
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Dan Littman has defined key transcriptional regulators of T helper cell differentiation, particularly Th17 and regulatory T cells. His work linking the gut microbiome to systemic T cell responses has reshaped understanding of immune homeostasis and cancer immunosurveillance.

Share:

🧪Research Fields 研究领域

Th17/Treg DifferentiationTh17/Treg分化
Gut Immunity肠道免疫
T Cell Transcription FactorsT细胞转录因子

🎓Key Contributions 主要贡献

Th17 Cell Differentiation

Identified RORγt as the master transcription factor governing Th17 cell development, providing a molecular handle for therapeutic modulation.

Gut Microbiome and Immunity

Demonstrated that specific gut commensal bacteria drive Th17 responses systemically, connecting microbiome composition to cancer therapy outcomes.

Representative Works 代表性著作

[1]

The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells

Cell (2006)

Identified RORγt as the Th17 master regulator, a landmark discovery enabling targeted Th17 modulation in autoimmunity and cancer.

[2]

Induction of intestinal Th17 cells by segmented filamentous bacteria

Cell (2009)

Established causal link between a gut commensal bacterium and systemic Th17 responses, founding the microbiome-immunity interface field.

🏆Awards & Recognition 奖项与荣誉

🏆HHMI Investigator
🏆Vilcek Prize in Biomedical Science
🏆William B. Coley Award for Distinguished Research in Basic and Tumor Immunology

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 丹·利特曼 的研究动态

Follow Dan Littman's research updates

留下邮箱,当我们发布与 Dan Littman(NYU Langone Health)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment